Mirae Asset Global Investments Co., Ltd. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,066,813
-15.8%
286,743
+8.6%
0.02%
-13.0%
Q2 2023$10,771,195
+32.7%
264,110
+21.3%
0.02%
+21.1%
Q1 2023$8,114,759
+11.7%
217,729
+4.5%
0.02%0.0%
Q4 2022$7,266,575
-38.6%
208,271
-1.5%
0.02%
-40.6%
Q3 2022$11,831,000
+27.3%
211,423
+17.8%
0.03%
+33.3%
Q2 2022$9,292,000
-15.7%
179,525
+18.3%
0.02%
+100.0%
Q1 2022$11,028,000
+4.1%
151,748
+69.4%
0.01%
-47.8%
Q4 2021$10,592,000
-43.2%
89,581
-35.6%
0.02%
-51.1%
Q3 2021$18,648,000
+2.0%
139,015
+23.1%
0.05%
-7.8%
Q2 2021$18,279,000
+104.6%
112,902
+1.4%
0.05%
+64.5%
Q1 2021$8,933,000
+170.1%
111,298
+83.0%
0.03%
+158.3%
Q4 2020$3,307,000
+348.1%
60,802
+63.9%
0.01%
+200.0%
Q3 2020$738,000
+38.7%
37,102
+46.6%
0.00%
+33.3%
Q2 2020$532,000
+178.5%
25,307
+61.6%
0.00%
+200.0%
Q1 2020$191,000
-6.8%
15,656
+12.2%
0.00%0.0%
Q4 2019$205,000
+45.4%
13,954
+32.3%
0.00%0.0%
Q3 2019$141,00010,5470.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders